Us Bancorp \De\ Pulmonx Corp Transaction History

Us Bancorp \De\

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$7.89 - $13.14 $1,128 - $1,879	-143 Reduced 81.25%	33 $0
Q3 2023 Nov 03, 2023	SELL	$9.88 - $14.0 $13,930 - $19,740	-1,410 Reduced 88.9%	176 $1,000
Q2 2023 Aug 09, 2023	SELL	$10.78 - $13.65 $7,869 - $9,964	-730 Reduced 31.52%	1,586 $20,000
Q1 2023 May 09, 2023	BUY	$7.49 - $12.54 $12,088 - $20,239	1,614 Added 229.91%	2,316 $25,000
Q4 2022 Feb 13, 2023	BUY	$4.92 - $17.35 $1,485 - $5,239	302 Added 75.5%	702 $5,000
Q3 2022 Oct 27, 2022	SELL	$15.35 - $23.99 $1,013 - $1,583	-66 Reduced 14.16%	400 $7,000
Q2 2022 Aug 01, 2022	BUY	$14.0 - $27.95 $1,246 - $2,487	89 Added 23.61%	466 $7,000
Q1 2022 May 11, 2022	SELL	$21.13 - $35.65 $25,630 - $43,243	-1,213 Reduced 76.29%	377 $10,000
Q4 2021 Feb 11, 2022	BUY	$29.72 - $45.1 $16,643 - $25,256	560 Added 54.37%	1,590 $51,000
Q3 2021 Nov 10, 2021	BUY	$35.98 - $44.48 $19,213 - $23,752	534 Added 107.66%	1,030 $37,000
Q2 2021 Aug 05, 2021	BUY	$37.61 - $48.0 $18,654 - $23,808	496 New	496 $22,000

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.